A California appellate panel ordered that claims alleging pancreatic cancer caused by diabetes drug manufacturers Merck & Co., Eli Lilly & Co., AstraZeneca’s Amylin Pharmaceuticals, and Novo Nordisk Inc., should move forward in state court.
Three Motley Rice attorneys were recognized as 2018 Connecticut Super Lawyers® and Rising Stars.
Six Motley Rice attorneys are 2018 Rhode Island and New York Metro Super Lawyers® and Rising Stars.
U.S. District Judge Manish S. Shah appointed antitrust attorney Michelle Clerkin to the Plaintiffs’ Steering Committee for Volatility Index (VIX) multidistrict litigation.